NIH Shared Instrumentation Grants

In recognition of the longstanding need in the biomedical research. Used Equipment When an institution is awarded a government research grant or contract to perform work for which equipment must be obtained, it is a good idea to inquire whether the necessary pieces may be available through the Excess Property program of the particular agency for which the work is being done. Federal agencies that award research grants and contracts to profit-making organizations usually retain title to any

| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

In recognition of the longstanding need in the biomedical research.

When an institution is awarded a government research grant or contract to perform work for which equipment must be obtained, it is a good idea to inquire whether the necessary pieces may be available through the Excess Property program of the particular agency for which the work is being done.

Federal agencies that award research grants and contracts to profit-making organizations usually retain title to any scientific equipment purchased with agency funds. When the work is completed, the property reverts to the granting agency, which may pass it along to another contractor or grantee.

When the agency has-no need for the equipment, it is reported to the General Services Administration (GSA) as excess property. At regular intervals, GSA publishes a list, distributed to all federal agencies, of excess-property items. Any federal agency may request transfer to it of equipment listed. ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies